Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma

ClinicalTrials.gov ID: NCT00070187

Public ClinicalTrials.gov record NCT00070187. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 6:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II/III Study of Immunomodulation After High Dose Myeloablative Therapy With Autologous Stem Cell Rescue for Refractory/Relapsed Hodgkin Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with autologous stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. Giving immunotherapy using cyclosporine, interferon gamma, and interleukin-2 after stem cell transplantation may help the transplanted cells make an immune response and kill any remaining cancer cells. It is not yet known whether high-dose chemotherapy followed by autologous stem cell transplantation is more effective with or without immunotherapy. PURPOSE: This randomized phase II/III trial is studying how well high-dose chemotherapy followed by autologous stem cell transplantation, cyclosporine, interferon gamma, and interleukin-2 works and compares it to high-dose chemotherapy followed by autologous stem cell transplantation only in treating patients with refractory or relapsed Hodgkin's lymphoma.

Study identification

NCT ID
NCT00070187
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Children's Oncology Group
Network
Enrollment
24 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Up to 30 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2003 (Type not available)
Primary completion
Jun 2005 (Actual)
Completion
Not listed
Last update posted
Oct 17, 2013

Started 2003

United States locations

U.S. sites
60
U.S. states
28
U.S. cities
56
Facility City State ZIP Site status
Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham Alabama 35294 —
Phoenix Children's Hospital Phoenix Arizona 85016-7710 —
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock Arkansas 72205 —
Jonsson Comprehensive Cancer Center at UCLA Los Angeles California 90095-1781 —
Children's Hospital and Research Center - Oakland Oakland California 94609-1809 —
Children's Hospital of Orange County Orange California 92868 —
Kaiser Permanente Medical Center - Oakland Sacramento California 95825 —
Alfred I. duPont Hospital for Children Wilmington Delaware 19899 —
Children's National Medical Center Washington D.C. District of Columbia 20010-2970 —
University of Florida Shands Cancer Center Gainesville Florida 32610-0232 —
Nemours Children's Clinic Jacksonville Florida 32207 —
University of Miami Sylvester Comprehensive Cancer Center Miami Florida 33136 —
Miami Children's Hospital Miami Florida 33155 —
All Children's Hospital St. Petersburg Florida 33701 —
St. Joseph's Cancer Institute at St. Joseph's Hospital Tampa Florida 33607 —
Kaplan Cancer Center at St. Mary's Medical Center West Palm Beach Florida 33407 —
Emory University Hospital - Atlanta Atlanta Georgia 30322 —
Children's Memorial Hospital - Chicago Chicago Illinois 60614 —
Southern Illinois University School of Medicine Springfield Illinois 62794-9620 —
Indiana University Cancer Center Indianapolis Indiana 46202-5289 —
St. Vincent Indianapolis Hospital Indianapolis Indiana 46260 —
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Kansas City Kansas 66160-7357 —
Kosair Children's Hospital Louisville Kentucky 40232 —
Children's Hospital of New Orleans New Orleans Louisiana 70118 —
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21231-2410 —
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 —
C.S. Mott Children's Hospital at University of Michigan Ann Arbor Michigan 48109-0238 —
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201-1379 —
Hurley Medical Center Flint Michigan 48503 —
Spectrum Health Cancer Care - Butterworth Campus Grand Rapids Michigan 49503-2560 —
Van Elslander Cancer Center at St. John Hospital and Medical Center Grosse Pointe Woods Michigan 48236 —
Children's Hospital of Minnesota - Minneapolis Minneapolis Minnesota 55404 —
Fairview University Medical Center - University Campus Minneapolis Minnesota 55455 —
Mayo Clinic Cancer Center Rochester Minnesota 55905 —
University of Mississippi Medical Center Jackson Mississippi 39216-4505 —
Children's Mercy Hospital Kansas City Missouri 64108 —
Hackensack University Medical Center Cancer Center Hackensack New Jersey 07601 —
Roswell Park Cancer Institute Buffalo New York 14263-0001 —
Mount Sinai Medical Center New York New York 10029 —
Long Island Cancer Center at Stony Brook University Hospital Stony Brook New York 11794-8174 —
SUNY Upstate Medical University Hospital Syracuse New York 13210 —
New York Medical College Valhalla New York 10595 —
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229-3039 —
Rainbow Babies and Children's Hospital Cleveland Ohio 44106-5000 —
Children's Medical Center - Dayton Dayton Ohio 45404-1815 —
Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey Pennsylvania 17033-0850 —
Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15213 —
Hollings Cancer Center at Medical University of South Carolina Charleston South Carolina 29425 —
St. Jude Children's Research Hospital Memphis Tennessee 38105 —
Texas Tech University Health Sciences Center School of Medicine Amarillo Texas 79106 —
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas Texas 75390 —
Cook Children's Medical Center - Fort Worth Fort Worth Texas 76104-9958 —
Covenant Children's Hospital Lubbock Texas 79410 —
University of Texas Health Science Center at San Antonio San Antonio Texas 78229-3900 —
Methodist Children's Hospital of South Texas San Antonio Texas 78229-3993 —
CCOP - Scott and White Hospital Temple Texas 76508 —
Children's Hospital of the King's Daughters Norfolk Virginia 23507-1971 —
St. Vincent Hospital Regional Cancer Center Green Bay Wisconsin 54307-3508 —
Marshfield Clinic - Marshfield Center Marshfield Wisconsin 54449 —
Midwest Children's Cancer Center Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00070187, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 17, 2013 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00070187 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →